According to the ADA, total annual costs associated with diagnosed diabetes cases increased by 41% between 2007 and 2012, and the total estimated cost for care of those in the U.S. with diagnosed diabetes in 2012 was $245 billion. People diagnosed with diabetes spend about $13,700 per year on medical …
Read More »Monthly Archives: September 2014
Empagliflozin/linagliptin Combo Tablet Shows Sustained Reduction in BG
Boehringer Ingelheim, and Eli Lilly & Co. have presented results from a 52-week Phase III study demonstrating sustained efficacy of the investigational empagliflozin/linagliptin combination tablet in adults with T2DM already taking metformin and in those who were previously untreated. The results, presented during the 50th Annual Meeting of the European …
Read More »Optimal A1c for Detecting Diabetes in Early Pregnancy
An HbA1c higher than 5.9% was a more accurate indicator for diabetes in pregnant patients….
Read More »Statins May Protect against Microvascular Complications of Diabetes
Complications that can lead to blindness, nerve damage, and kidney damage could be reduced by taking statins….
Read More »High-salt Diet and High HBA1c May Increase Cardiovascular Disease
A synergistic effect may exist between HbA1c level and dietary sodium intake for the development of CVD….
Read More »Weight Loss Lowers Health Care Costs for Type 2 Diabetic Patients
Overweight diabetic patients who lose weight by dieting and increasing their physical activity can reduce their health care costs by an average of around $600 per year….
Read More »Fibrates Can Reduce Cardiovascular Risk in Type 2’s
This study showed that fenofibrate was very effective in lowering total, LDL, non-HDL cholesterol significantly in female diabetic patients compared to male patients….
Read More »Painful Diabetic Peripheral Neuropathy Patients Treated Successfully with Spinal Cord Stimulation
A clinical trial showed that SCS provided pain relief in patients with PDPN….
Read More »LX4211 Improved Glucose Control without Dose-Increasing Glucosuria in Type 2 Diabetes
In patients with type 2 diabetes, LX4211 produced greater dose-ranging effects on HbA1c than on glucosuria….
Read More »Diabetic Coronary Atherosclerosis Regression Seen with High-Intensity Statin Therapy
High-intensity statin therapy altered the progressive nature of coronary atheroma in diabetic and nondiabetic patients….
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.